Evidence map›Paper›PMID 27251632›Full record

ArticleRadiation oncology (London, England)2016

Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.

Johann Matschke, Elisa Wiebeck, Sebastian Hurst, Justine Rudner, Verena Jendrossek

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Oncometabolites and the response to radiotherapy.Radiation oncology (London, England) · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Johann MatschkeInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, University Hospital Essen, Virchowstrasse 173, 45122, Essen, Germany.
Elisa WiebeckInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, University Hospital Essen, Virchowstrasse 173, 45122, Essen, Germany.
Sebastian HurstInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, University Hospital Essen, Virchowstrasse 173, 45122, Essen, Germany.
Justine RudnerInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, University Hospital Essen, Virchowstrasse 173, 45122, Essen, Germany.
Verena JendrossekInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, University Hospital Essen, Virchowstrasse 173, 45122, Essen, Germany. verena.jendrossek@uni-due.de.
Essen University Hospital · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnsaturated fatty acids (FA) are required for cancer cell growth. In normoxia cells can generate unsaturated FA from saturated stearic and palmitic acid by desaturation. However, since the desaturation step is oxygen-dependent hypoxic cancer cells display an increased dependence on the uptake of unsaturated FA. Up to now the mechanism of increased FA uptake in hypoxia is largely unknown. Here we aimed to study the role of human serum and glucocorticoid-inducible kinase (SGK1) in the regulation of FA uptake in cancer cells exposed to acute or chronic cycling hypoxia and explore its use as target for the radiosensitization of hypoxic cancer cells.

methodsThe effect of SGK1-inhibition (GSK650394) on NCI-H460 lung adenocarcinoma cells exposed to normoxia, acute or chronic cycling hypoxia was analyzed under standard and serum-deprived conditions by short-term proliferation, apoptosis and cell death assays. The impact of SGK1-inhibition on radiation sensitivity was determined by standard colony formation assays. The effect of GSK650394 on FA uptake was quantified by measuring intracellular accumulation of fluorescent FA (C1-BODIPY®-C12).

resultsExposure to acute or chronic cycling hypoxia was associated with up-regulated expression of SGK1 in NCI-H460 cells, increased uptake of FA from the culture medium, and increased sensitivity to serum deprivation. Survival of serum-deprived hypoxic NCI-H460 cells was rescued by the addition of the unsaturated FA, oleic acid, whereas the saturated FA, palmitic acid was highly toxic to the hypoxic cancer cells. Interestingly, SGK1 inhibition abrogated the rescue effect of oleic acid in serum-deprived hypoxic cancer cells and this effect was associated with a reduction in FA uptake particularly in anoxia-tolerant cancer cells exposed to severe hypoxia. Finally, SKG1 inhibition decreased long-term survival and potently sensitized the parental and anoxia-tolerant NCI-H460 cells to the cytotoxic effects of ionizing radiation in normoxia as well as the anoxia-tolerant cancer cells in severe hypoxia.

conclusionsOur data suggest that SGK1 plays a role in the regulation of FA uptake that becomes essential under conditions of acute or chronic cycling hypoxia. We assume that SGK1 may represent a promising therapeutic target for the eradication of hypoxic cancer cells.

Indexed as

Radiation ToleranceAcute DiseaseAdenocarcinomaApoptosisBlotting, WesternCell ProliferationChronic DiseaseFatty AcidsFlow CytometryHumansHypoxiaImmediate-Early ProteinsLung NeoplasmsProtein Serine-Threonine KinasesReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionFatty AcidsImmediate-Early ProteinsProtein Serine-Threonine KinasesRNA, MessengerSerum-Glucocorticoid Regulated KinasesFatty acid uptakeHypoxiaIonizing radiationOleic acidRadioresistanceSCD1SGK1Unsaturated fatty acids

Identifiers

PMID27251632
PMCPMC4888512
OpenAlexW2412573634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.